Loading...
CXCL12 (SDF1α) – CXCR4/CXCR7 Pathway Inhibition: An Emerging Sensitizer for Anti-Cancer Therapies?
Addition of multiple molecularly targeted agents to the existing armamentarium of chemotherapeutics and radiotherapies represents a significant advance in the management of several advanced cancers. In certain tumor types with no efficacious therapy options, these agents have become the first line o...
Na minha lista:
Main Authors: | , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
2011
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3079023/ https://ncbi.nlm.nih.gov/pubmed/21349998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-2636 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|